David Aguiar

Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions

Clara Mayo‐de‐las‐Casas, Núria Jordana‐Ariza, Mónica Garzón‐Ibáñez et al. · Annals of Oncology · 2017 · 98 citations · Full text

Medicine, Genetics, Oncology +13

Toxic Epidermal Necrolysis in Patients Receiving Anticonvulsants and Cranial Irradiation: A Risk to Consider

David Aguiar, Roberto Pazo, Ignacio Durán et al. · Journal of Neuro-Oncology · 2004 · 79 citations

Medicine, Neurology, Toxicology +15

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

Esther Conde, Susana Hernández, Rebeca Martínez et al. · Journal of Thoracic Oncology · 2019 · 73 citations · Full text

Medicine, Molecular Biology, Oncology +17

Clear-PEM: A PET imaging system dedicated to breast cancer diagnostics

M.C. Abreu, David Aguiar, E. Albuquerque et al. · Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment · 2006 · 32 citations · Full text

Medicine, Nuclear Medicine, Radiology +14

Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial

A. Rueda, Ruth Vera, Alicia Lozano et al. · Annals of Oncology · 2012 · 31 citations

Medicine, Oncology, Pharmacology +9